Bone Marrow CD133+ Stem/Progenitor Cells, Fresh
Bone marrow mononuclear cells (MNCs) are separated from whole bone marrow by a density gradient centrifugation protocol. CD133+ stem and progenitor cells are positively selected using immunomagnetic anti-CD133 (clone AC133) microbeads from the MNC population. CD133+ cells are characterized by flow cytometry to ensure a highly pure and viable cell population.
Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.
|Cell and Tissue Source||Bone Marrow|
|Cell Type||Stem/Progenitor Cells|
|Purity||≥90% by Flow Cytometry|
|Viability||≥85% by Flow Cytometry|